Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency; Guidance for Industry and Food and Drug Administration Staff; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency." The guidance describes general recommendations for the validation of in vitro diagnostic devices (IVDs) for emerging pathogens during an applicable declaration of public health emergency (PHE). This guidance and the associated template include the recommendations that apply to test data and information submitted in a pre-Emergency Use Authorization (EUA), an EUA request, or to a test offered as described in an applicable enforcement discretion policy.
- quotes — Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency; Guidance for Industry and Food and Drug Administration Staff; Availability (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/10/2026-22883/validation-of-certain-in-vitro-diagnostic-devices-for-emerging-pathogens-during-a-section-564; status: unverified)
- quotes — summary: The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency." The guidance describes general recommendations for the validation of in vitro diagnostic devices (IVDs) for emerging pathogens during an applicable declaration of public health emergency (PHE). This guidance and the associated template include the recommendations that apply to test data and information submitted in a pre-Emergency Use Authorization (EUA), an EUA request, or to a test offered as described in an applicable enforcement discretion policy. (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/10/2026-22883/validation-of-certain-in-vitro-diagnostic-devices-for-emerging-pathogens-during-a-section-564; status: unverified)
- quotes — url: https://www.federalregister.gov/documents/2026/11/10/2026-22883/validation-of-certain-in-vitro-diagnostic-devices-for-emerging-pathogens-during-a-section-564 (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/10/2026-22883/validation-of-certain-in-vitro-diagnostic-devices-for-emerging-pathogens-during-a-section-564; status: unverified)
- quotes — source-subject: federal-register:2026-22883 (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/10/2026-22883/validation-of-certain-in-vitro-diagnostic-devices-for-emerging-pathogens-during-a-section-564; status: unverified)
- quotes — source-edition: ni:///sha-256;ml_4S00qw-97m8Q0kceU7ds_RqyB-d9WeeMhbQPK3f4 (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/10/2026-22883/validation-of-certain-in-vitro-diagnostic-devices-for-emerging-pathogens-during-a-section-564; status: unverified)
- quotes — source-metadata: {"subject":"federal-register:2026-22883","revision":"ni:///sha-256;ml_4S00qw-97m8Q0kceU7ds_RqyB-d9WeeMhbQPK3f4","documentNumber":"2026-22883","documentUrl":"https://www.federalregister.gov/documents/2026/11/10/2026-22883/validation-of-certain-in-vitro-diagnostic-devices-for-emerging-pathogens-during-a-section-564","title":"Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency; Guidance for Industry and Food and Drug Administration Staff; Availability","documentType":"Notice","publicationDate":"2026-11-10","publicationDatePrecision":"civil-day","agencies":["Food and Drug Administration","Health and Human Services Department"],"abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled \"Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency.\" The guidance describes general recommendations for the validation of in vitro diagnostic devices (IVDs) for emerging pathogens during an applicable declaration of public health emergency (PHE). This guidance and the associated template include the recommendations that apply to test data and information submitted in a pre-Emergency Use Authorization (EUA), an EUA request, or to a test offered as described in an applicable enforcement discretion policy.","commentsCloseOn":null,"commentDeadlineFieldRequested":true,"effectiveOn":null,"sourceAction":"Notice of availability.","federalRegisterCitation":"91 FR 72541","docketIds":["Docket No. FDA-2024-D-2707"],"regulationIdNumbers":[],"cfrReferences":[],"correctionOf":null,"corrections":[],"source":{"originalApiUrl":"https://www.federalregister.gov/api/v1/documents.json?conditions%5Bpublication_date%5D%5Bgte%5D=2026-11-05&conditions%5Bpublication_date%5D%5Blte%5D=2026-11-12&per_page=100&page=2&order=newest&fields%5B%5D=document_number&fields%5B%5D=title&fields%5B%5D=type&fields%5B%5D=abstract&fields%5B%5D=html_url&fields%5B%5D=publication_date&fields%5B%5D=agencies&fields%5B%5D=comments_close_on&fields%5B%5D=effective_on&fields%5B%5D=action&fields%5B%5D=citation&fields%5B%5D=regulation_id_numbers&fields%5B%5D=cfr_references&fields%5B%5D=docket_ids&fields%5B%5D=correction_of&fields%5B%5D=corrections","originalResponseDigest":"sha256:be28a42f3dceaf0a984518966928a87d5626f2fa3836d1673cc2514c9838dfbc","originalResponseUri":"ni:///sha-256;viikLz3OrwqYRRiWaSiofVYm8vo4NtFnPMJRTJg437w","normalizedLotDigest":"sha256:2c5f3428371101732140a1f82e64e981b1bf3b50fb869c5de239ff9c59bd4335","observedAt":"2026-11-12T21:30:47.088Z","provider":"https://www.federalregister.gov","publisher":{"name":"Office of the Federal Register","source":"https://www.federalregister.gov/reader-aids/developer-resources/rest-api","reproduction":"https://www.archives.gov/federal-register/faqs","officialNotice":"The source Federal Register edition, not this derived JSON, is authoritative. No government endorsement."},"evidenceClass":"source-dated government metadata, independently replayable from original HTTP bytes held by the source acquisition run"}} (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/10/2026-22883/validation-of-certain-in-vitro-diagnostic-devices-for-emerging-pathogens-during-a-section-564; status: unverified)
- quotes — editorial-standing: source metadata; editorial acceptance pending (witness: https://www.federalregister.gov; method: quoted collector metadata from an original HTTP response; citation: https://www.federalregister.gov/documents/2026/11/10/2026-22883/validation-of-certain-in-vitro-diagnostic-devices-for-emerging-pathogens-during-a-section-564; status: unverified)